The U.S. Food and Drug Administration’s database indicates that the abbreviated new drug application (ANDA) 087157 for the product FLUONID has a marketing status of "Discontinued." FLUONID is a topical ointment containing 0.025% fluocinonide. The product is not designated as a reference drug and does not have a reference standard. The sponsor listed for this ANDA is Allergan Herbert. No further details on the reason for discontinuation are provided in the FDA entry.
Actualités réglementaires5 sept. 2026•1 min de lecture
FDA Discontinues FLUONID Topical Ointment (ANDA 087157)
The FDA lists the FLUONID ointment (0.025% fluocinonide) under ANDA 087157 as discontinued, sponsored by Allergan Herbert.
Compilé par l'équipe PharmaCountry · Source : FDA.gov
Évaluations
(0)
(0)
(0)
(0)
(0)
Plus d'articles
Voir tous les articlesRecherches & Rapports
Global Finished Dosage Manufacturing Landscape 2026
5 oct. 2026
Actualités réglementairesKorea Korus hit with 1‑month manufacturing suspension over missing post‑marketing safety test
28 sept. 2026
AnalysePharma distributors set delivery cut‑offs ahead of Chuseok holiday (Sep 21‑23)
28 sept. 2026
Laissez votre note